LEHI, UT, April 11, 2024 – Lumea Inc., a forefront innovator in the digital pathology space, is pleased and honored to be announced the winner of Utah’s Best in State award for Medical Innovation. Lumea operates right in the heart of Silicon Slopes, recently named by the Wall Street Journal the top tech hub in the United States. When Stanford-trained pathologist Matthew Leavitt founded the digital pathology company in 2013, he aimed to improve patient care, increase access to lifesaving treatments, and protect and improve upon the practice he loved. Digital pathology is the means by which prac ..read more

Stop by Lumea’s booth at Transforming Digital Pathology AI: The Path Forward for an immersive experience with our cutting-edge digital pathology technology and to gain firsthand insights into how our technology optimizes pathology workflows. Lumea’s representatives will be available to engage in discussions, providing in-depth knowledge about their digital pathology solutions and addressing queries. This presents a unique opportunity for professionals at all levels, from beginners to experts, to explore and understand the practical applications of our technology in clinical settings. Whether i ..read more

Lumea, a prominent digital pathology company, is set to play a significant role in the upcoming 2024 Digital Pathology & AI Congress: USA. The company has secured a booth at the congress, providing an excellent platform to showcase its innovative solutions, engage with industry professionals, and contribute to the overall discourse on advancements in digital pathology and artificial intelligence (AI). Reach out to Bianca Collings today to reserve a spot for a personalized demo during the event. Event Details: The 2024 Digital Pathology & AI Congress: USA will take place May 7-8 in San ..read more

Digital pathology can offer several potential benefits for patients when implemented effectively. Whether it is “better” than traditional pathology depends on various factors, including the quality of workflow integration and the initial learning curve. This article outlines how digital pathology can enhance patient care while also shedding light on some hurdles and potential drawbacks. How Digital Pathology Can Benefit Patients 1. Faster Diagnosis and Second Opinion Turnaround Time When pathologists and labs are not co-located, digital pathology enables the immediate distribution of slides wi ..read more

Does digital pathology just create more work for histology lab staff? The short answer? Yes. Perhaps the better question is this: is digital pathology worth it even though it creates more work for histology lab staff? The answer to this question is: it depends. Adding the digital component certainly helps keep labs relevant, but is that all? Let’s dive in! How does digital pathology add to a lab’s workload? Once a slide is coverslipped the lab sends it straight to the pathologist. The pathologist may request re-cuts, additional stains, or consults, and a surgeon may request ancillary testin ..read more

Lumea will have a booth at the upcoming USCAP Annual Meeting this March. As pioneers in the field, Lumea continues to push the boundaries of digital pathology technology. Our solutions for urology promise to be a highlight of the event. Groups using Lumea’s pre-analytical and digital pathology tech have seen many benefits, including: A significant decrease in waste Up to a 10% increase in cancer detection rates Better tissue quality Improved workflow efficiency Event Details: The 113th USCAP Annual Meeting is March 23-28, 2024, in Baltimore, Maryland. The USCAP’s yearly conference stand ..read more

In our sixth Ask a Pathologist Podcast episode we had the privilege to interview Dr. Jared Szymanski about his top tips for pathology fellowships and his thoughts and opinions on digital pathology as an early adopter. Dr. Jared Szymanski graduated from the Midwestern University-Arizona College of Osteopathic Medicine in 2003. He works in Provo, UT and 2 other locations and specializes in pathology, dermatopathology and cytopathology. He was also one of the key founders and inventors of Lumea digital pathology when it was established back in 2013. Listen here: Watch on YouTube Here: https://you ..read more

In the ever-evolving landscape of medical histopathology, the quest for efficiency, standardization, and cost-effectiveness has driven groundbreaking innovations. At the forefront of this revolution is the BxChip® technology by Lumea, a transformative tissue microarray (TMA). This article delves into the exceptional features and benefits of BxChip, highlighting its impact on reducing costs, improving tissue yield and quality to enhance diagnosis, and revolutionizing histological processes. The BxChip: A Pioneer in Multiplexing Methods Launched in the United States in 2015, the Lumea BxChip sta ..read more

Diagnostic Artificial Intelligence (AI) and pathology workflow optimization tools are two distinct categories of technologies used in pathology laboratories. In this blog post, we will walk you through the differences and give some examples of each. Diagnostic AI Purpose:  Pathology diagnostic AI involves artificial intelligence (AI) algorithms that assist pathologists in the identification, interpretation, and diagnosis of medical images, particularly scanned histopathologic slides. Functionality: Image Analysis: AI algorithms can analyze digital pathology images to identify and so ..read more

Lumea, dedicated to advancing tissue standardization and digital pathology, solidified its position in the United States in the latest KLAS Research LEHI, UTAH, USA, February 8, 2024 /EINPresswire.com/ — Lumea, a trailblazing digital pathology company dedicated to advancing tissue standardization, solidified its position among the best digital pathology companies in the United States in the latest KLAS Research ‘US Digital Pathology 2023’ Performance Insights report. The report highlights an exciting success story from a urology practice that tried Lumea and experienced a substantial improveme ..read more